Bayer Stock Forecast for 2023 - 2025 - 2030
Updated on 02/01/2023
Bayer Stock Forecast and Price Target
According to twelve esteemed experts, the average price target for Bayer to reach this year is 75.50€, with a potential upside of approximately 32.46%. This prediction is based on a high estimate of 106.00€ and a low estimate of 54.00€. If you want to invest in BAYN stock, you might also want to take a look at how its competitors are doing.
32.46% Upside
Bayer Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, Bayer's Price has grown by 1.72%, rising from 53.25€ to 54.16€. For next year, analysts predict Fair Value of 67.48€, which would mean an increase of 24.58%. Over the next eight years, experts predict that Bayer's Fair Value will grow at a rate of 2.76%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABBV Stock Forecast | AbbVie | Outperform |
10
|
$147.74 | Buy/Sell | $162.12 | 11.68% |
| AZN Stock Forecast | AstraZeneca PLC | Outperform |
8
|
£10.59k | Buy/Sell | £153.20 | -98.53% |
| COST Stock Forecast | Costco Wholesale Corp | Outperform |
13
|
$511.23 | Buy/Sell | $550.07 | 7.09% |
| DHR Stock Forecast | Danaher Corp | Outperform |
10
|
$264.38 | Buy/Sell | $304.24 | 15.18% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
10
|
$110.55 | Buy/Sell | $116.63 | 13.07% |
Bayer Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Bayer's Revenue has grown by 1.23%, rising from 43.55€B to 44.08€B. For next year, analysts predict Revenue of 49.37€B, which would mean an increase of 12.00%. Over the next eight years, experts predict that Bayer's Revenue will grow at a rate of 16.35%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AMGN Stock Forecast | Amgen Inc | Hold |
7
|
$271.73 | Buy/Sell | $268.00 | 2.31% |
| CSL Stock Forecast | CSL | Outperform |
8
|
$301.85 | Buy/Sell | $218.60 | -25.11% |
| BDX Stock Forecast | Becton, Dickinson and | Outperform |
17
|
$252.22 | Buy/Sell | $268.00 | 9.03% |
.jpg)
Bayer Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Bayer's Dividend per Share has decreased by 28.57%, going from 2.80€ to 2.00€. For next year, analysts predict Dividend per Share of 2.45€, which would mean an increase of 22.50%. Over the next eight years, experts predict that Bayer's Dividend per Share will grow at a rate of 20.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GSK Stock Forecast | GSK | Hold |
16
|
£1.42k | Buy/Sell | £16.95 | -98.87% |
| CL Stock Forecast | Colgate-Palmolive Co | Outperform |
18
|
$74.53 | Buy/Sell | $81.35 | 10.02% |
| BAS Stock Forecast | BASF | Hold |
11
|
52.40€ | Buy/Sell | 53.50€ | 4.96% |
Bayer Free Cash Flow Forecast for 2023 - 2025 - 2030
Bayer's Free Cash Flow has decreased by 55.41% In the last two years, from 5.56€B to 2.48€B. In the next year, analysts believe that Free Cash Flow will reach 5.59€B – an increase of 125.74%. For the next eight years, experts predict that Bayer's Free Cash Flow will grow at a rate of 122.32%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CTVA Stock Forecast | Corteva | Outperform |
12
|
$64.44 | Buy/Sell | $73.12 | 13.28% |
| DOW Stock Forecast | Dow | Hold |
11
|
$59.35 | Buy/Sell | $54.73 | -8.17% |
| DD Stock Forecast | DuPont de Nemours | Outperform |
17
|
$73.95 | Buy/Sell | $80.00 | 8.18% |
Bayer Net Income Forecast for 2023 - 2025 - 2030
In the last two years, Bayer's Net Income has decreased from 4.09€B to 1000.00€M – a 75.56% drop. In the next year, analysts believe that Net Income will reach 7.93€B – an increase of 692.94%. For the next eight years, the forecast is for Net Income to grow by 557.30%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SGO Stock Forecast | Compagnie de Saint-Gobain | Outperform |
18
|
52.38€ | Buy/Sell | 71.19€ | 40.32% |
| GIVN Stock Forecast | Givaudan | Hold |
18
|
CHF2.93k | Buy/Sell | CHF4.11k | 4.06% |
| GMAB Stock Forecast | Genmab A/S | Outperform |
16
|
kr3.00k | Buy/Sell | kr2.84k | -8.24% |
Bayer EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Bayer's EBITDA has decreased from 10.81€B to 8.42€B – a 22.08% drop! In the next year, analysts believe that EBITDA will reach 13.29€B – an increase of 57.78%. For the next eight years, the forecast is for EBITDA to grow by 79.91%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALNY Stock Forecast | Alnylam Pharmaceuticals | Outperform |
7
|
$226.40 | Buy/Sell | $244.18 | 10.87% |
| 4503 Stock Forecast | Astellas Pharma | Outperform |
18
|
¥1.92k | Buy/Sell | ¥0.00 | 24.74% |
| BEI Stock Forecast | Beiersdorf | Outperform |
17
|
111.60€ | Buy/Sell | 110.36€ | 3.05% |
Bayer EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Bayer's EBIT has grown by 2.46%, rising from 6.98€B to 7.15€B. For the next year, analysts predict that EBIT will reach 8.95€B – an increase of 25.09%. Over the next eight years, experts believe that Bayer's EBIT will grow at a rate of 54.24%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAX Stock Forecast | Baxter International | Outperform |
17
|
$45.69 | Buy/Sell | $62.83 | 26.94% |
| 1301 Stock Forecast | Formosa Plastics | Outperform |
18
|
NT$88.60 | Buy/Sell | NT$125.45 | 49.55% |
| 4523 Stock Forecast | Eisai | Hold |
18
|
¥8.15k | Buy/Sell | ¥0.00 | -18.99% |
Bayer EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, Bayer's EPS has grown by 1.72%, rising from 6.40€ to 6.51€. For next year, analysts predict EPS of 8.11€, which would mean an increase of 24.58%. Over the next eight years, experts predict that Bayer's EPS will grow at a rate of 2.76%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CHD Stock Forecast | Church & Dwight Co Inc | Hold |
11
|
$80.87 | Buy/Sell | $82.17 | 5.11% |
| AKZA Stock Forecast | Akzo Nobel N.V. | Outperform |
18
|
65.30€ | Buy/Sell | 113.10€ | 66.16% |
| BIM Stock Forecast | bioMérieux | Outperform |
18
|
96.70€ | Buy/Sell | 105.55€ | 11.17% |
.jpg)